Bionexus gene lab corp. announces successful securities commission of malaysia (mycif) co-investment in ascension innovation sdn bhd

Kuala lumpur, malaysia, aug. 27, 2024 (globe newswire) -- bionexus gene lab corp. (nasdaq: bglc), an emerging leader in genomic diagnostics and personalized medicine, is pleased to announce the successful co-investment by the securities commission of malaysia under its malaysia co-investment fund (mycif), into ascension innovation sdn bhd (aisb). this co-investment, alongside bglc's recent investment, the first under its environmental & social impact (esi) scheme shows confidence in the strategic direction and potential of aisb.
BGLC Ratings Summary
BGLC Quant Ranking